Director Strategic Pricing
- Employer
- CSL
- Location
- King of Prussia, PA
- Start date
- Sep 13, 2024
View more categoriesView less categories
- Discipline
- Marketing, Market Access
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
Role Overview:
The Director of Strategic Pricing is responsible for pricing valuation during the early and late stages of medicine development, accountable for developing launch pricing strategies, and optimizing the launch sequence for pipeline and peri-launch assets. This role will focus on ensuring optimal pricing strategies for the assigned products. The position requires deep expertise in broad pricing strategies, reimbursement landscape, payer segments, and pricing regulations in both the US and key international markets. This role reports directly to the Senior Director, Pricing Center of Excellence.
Key Responsibilities:
Pricing Strategy: Conduct payer and pricing research in the US and key international markets to inform strategic pricing decisions for assigned pipeline and peri-launch assets. Ensure pricing strategies represent the value of our products and support their development and innovation.
Asset Value Maximization: Develop and execute global pricing strategies which maximize the asset total life cycle value, while being responsible for patient access and public health.
Market Access Plan: Provide strategic pricing input for payer value propositions and integrated access strategies. Develop and execute pricing strategy as part of the integrated Market Access Plan (MAP).
Collaborate with Cross-functional Teams: Work closely with Product Access Strategy, other Market Access function Center of Excellence (COE) and other partner functions to integrate pricing considerations into the brand Market Access strategy and ensure effective execution.
Business Development: Conduct pricing valuation and provide pricing recommendations for business development & licensing (BD&L) assets.
International reference pricing: Create and manage launch pricing strategies and global launch sequencing to optimize International Reference Pricing (IRP).
Innovative pricing models: Develop differentiated pricing guidelines including Innovative pricing models (IPM), where applicable. Utilize advanced modeling tools and scenario analysis to inform pricing decisions.
Lifecycle Management: Support the ongoing development of lifecycle optimization of pricing strategies to maintain and enhance P&R throughout the product lifecycle.
Market Insights for Planning: Provide pricing insights to support forecasting and long-range planning, including analysis of key pricing regulation changes and risk assessments.
Qualifications:
Experience: At least 10 years of experience in market access and pricing, with significant exposure to healthcare systems in both the US and key international markets.
Track Record: Demonstrated success in securing and optimizing pricing, reimbursement, and patient access in both the US and key international markets.
Knowledge: Extensive understanding of pricing regulations, payer landscapes, and market access dynamics in both the US and key international markets.
Collaboration: Proven ability to work effectively in cross-functional teams, with strong communication and influencing skills.
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
About CSL BehringCSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
We want CSL to reflect the world around usAs a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.
Do work that matters at CSL Behring!Company
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Areas of Expertise
We focus and demonstrate global leadership in three distinct areas—rare and serious diseases; influenza vaccines; and iron deficiency and nephrology.
Rare & Serious Diseases
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Vaccines
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries.
Iron Deficiency & Nephrology
With our iron deficiency and iron deficiency anemia expertise in heart failure, kidney disease, gastroenterology or inflammatory bowel disease, patient blood management and women’s health, we help patients affected by these conditions to live better, healthier lives.
- Phone
- 610-878-4000
- Location
-
1020 First Avenue
King of Prussia
Pennsylvania
19406
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert